153 related articles for article (PubMed ID: 32771677)
21. MALT1 substrate cleavage: what is it good for?
Moud BN; Ober F; O'Neill TJ; Krappmann D
Front Immunol; 2024; 15():1412347. PubMed ID: 38863711
[TBL] [Abstract][Full Text] [Related]
22. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cell Immunol; 2020 Aug; 354():104147. PubMed ID: 32593012
[TBL] [Abstract][Full Text] [Related]
23. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
24. Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.
Zhang YY; Peng J; Luo XJ
Biochem Pharmacol; 2022 Apr; 198():114977. PubMed ID: 35218741
[TBL] [Abstract][Full Text] [Related]
25. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
26. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
[TBL] [Abstract][Full Text] [Related]
27. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
[TBL] [Abstract][Full Text] [Related]
28. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
30. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
[TBL] [Abstract][Full Text] [Related]
31. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
Gewies A; Graß C; Krappmann D
Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
[TBL] [Abstract][Full Text] [Related]
32. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
[No Abstract] [Full Text] [Related]
33. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
[TBL] [Abstract][Full Text] [Related]
34. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.
Li Q; He J; Li S; Tian C; Yang J; Yuan H; Lu Y; Fagone P; Nicoletti F; Xiang M
Clin Immunol; 2023 Mar; 248():109217. PubMed ID: 36581220
[TBL] [Abstract][Full Text] [Related]
35. Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9.
Holliday MJ; Ferrao R; de Leon Boenig G; Estevez A; Helgason E; Rohou A; Dueber EC; Fairbrother WJ
J Biol Chem; 2018 Oct; 293(43):16803-16817. PubMed ID: 30206119
[TBL] [Abstract][Full Text] [Related]
36. CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
Ruland J; Hartjes L
Nat Rev Immunol; 2019 Feb; 19(2):118-134. PubMed ID: 30467369
[TBL] [Abstract][Full Text] [Related]
37. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma.
Sezer A; Mahmutović L; Akçeşme B
Med Oncol; 2023 Dec; 41(1):37. PubMed ID: 38155268
[TBL] [Abstract][Full Text] [Related]
38. From MALT lymphoma to the CBM signalosome: three decades of discovery.
Rosebeck S; Rehman AO; Lucas PC; McAllister-Lucas LM
Cell Cycle; 2011 Aug; 10(15):2485-96. PubMed ID: 21750409
[TBL] [Abstract][Full Text] [Related]
39. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.
Wang L; Guo Y; Huang WJ; Ke X; Poyet JL; Manji GA; Merriam S; Glucksmann MA; DiStefano PS; Alnemri ES; Bertin J
J Biol Chem; 2001 Jun; 276(24):21405-9. PubMed ID: 11259443
[TBL] [Abstract][Full Text] [Related]
40. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B.
Bertin J; Wang L; Guo Y; Jacobson MD; Poyet JL; Srinivasula SM; Merriam S; DiStefano PS; Alnemri ES
J Biol Chem; 2001 Apr; 276(15):11877-82. PubMed ID: 11278692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
